WO1986001724A1 - Pesticides derives de la xanthine - Google Patents
Pesticides derives de la xanthine Download PDFInfo
- Publication number
- WO1986001724A1 WO1986001724A1 PCT/US1985/001708 US8501708W WO8601724A1 WO 1986001724 A1 WO1986001724 A1 WO 1986001724A1 US 8501708 W US8501708 W US 8501708W WO 8601724 A1 WO8601724 A1 WO 8601724A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- xanthine
- pest
- substituted
- dimethyl
- hydrogen
- Prior art date
Links
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title claims abstract description 59
- 241000607479 Yersinia pestis Species 0.000 title claims description 27
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 16
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 55
- 150000001875 compounds Chemical class 0.000 claims description 44
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 claims description 37
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 claims description 37
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims description 36
- 230000005764 inhibitory process Effects 0.000 claims description 32
- 239000003795 chemical substances by application Substances 0.000 claims description 31
- 125000004432 carbon atom Chemical group C* 0.000 claims description 22
- 229930195733 hydrocarbon Natural products 0.000 claims description 21
- 239000007921 spray Substances 0.000 claims description 21
- 125000003118 aryl group Chemical group 0.000 claims description 20
- 229960000278 theophylline Drugs 0.000 claims description 20
- 125000005843 halogen group Chemical group 0.000 claims description 19
- 229910052739 hydrogen Inorganic materials 0.000 claims description 19
- 239000001257 hydrogen Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- 125000001931 aliphatic group Chemical group 0.000 claims description 18
- 125000000951 phenoxy group Chemical class [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 18
- 210000005036 nerve Anatomy 0.000 claims description 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 12
- 230000002401 inhibitory effect Effects 0.000 claims description 12
- 229910052717 sulfur Chemical group 0.000 claims description 12
- 239000011593 sulfur Chemical group 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 150000002430 hydrocarbons Chemical class 0.000 claims description 9
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 claims description 7
- 241000256011 Sphingidae Species 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- NUZFZZOVBJUJQN-UHFFFAOYSA-N 1,3-bis(prop-2-enyl)-7h-purine-2,6-dione Chemical compound O=C1N(CC=C)C(=O)N(CC=C)C2=C1NC=N2 NUZFZZOVBJUJQN-UHFFFAOYSA-N 0.000 claims description 5
- GIMNFISWKTZFKJ-UHFFFAOYSA-N 1,3-diethyl-7h-purine-2,6-dione Chemical compound O=C1N(CC)C(=O)N(CC)C2=C1NC=N2 GIMNFISWKTZFKJ-UHFFFAOYSA-N 0.000 claims description 5
- MJVIGUCNSRXAFO-UHFFFAOYSA-N 1,3-dipropyl-7h-purine-2,6-dione Chemical compound O=C1N(CCC)C(=O)N(CCC)C2=C1NC=N2 MJVIGUCNSRXAFO-UHFFFAOYSA-N 0.000 claims description 5
- QCIARNIKNKKHFH-UHFFFAOYSA-N 7-(2-chloroethyl)-1,3-dimethylpurine-2,6-dione Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CCCl)C=N2 QCIARNIKNKKHFH-UHFFFAOYSA-N 0.000 claims description 5
- KYHQZNGJUGFTGR-UHFFFAOYSA-N Proxyphylline Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2CC(O)C KYHQZNGJUGFTGR-UHFFFAOYSA-N 0.000 claims description 5
- 239000000440 bentonite Substances 0.000 claims description 5
- 229910000278 bentonite Inorganic materials 0.000 claims description 5
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 5
- 239000000428 dust Substances 0.000 claims description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 4
- 230000018791 negative regulation of catalytic activity Effects 0.000 claims description 4
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 3
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 3
- 235000012211 aluminium silicate Nutrition 0.000 claims description 3
- 229960000892 attapulgite Drugs 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 229910052602 gypsum Inorganic materials 0.000 claims description 3
- 239000010440 gypsum Substances 0.000 claims description 3
- 239000004571 lime Substances 0.000 claims description 3
- 229910052625 palygorskite Inorganic materials 0.000 claims description 3
- 229910052903 pyrophyllite Inorganic materials 0.000 claims description 3
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical class [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 claims description 3
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 3
- 239000000454 talc Substances 0.000 claims description 3
- 229910052623 talc Inorganic materials 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 14
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims 8
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 6
- NHCLZKKZQJJXER-UHFFFAOYSA-N 1,3-dibenzyl-7h-purine-2,6-dione Chemical compound C1=2N=CNC=2C(=O)N(CC=2C=CC=CC=2)C(=O)N1CC1=CC=CC=C1 NHCLZKKZQJJXER-UHFFFAOYSA-N 0.000 claims 4
- HRWQHFZQHIUCCC-UHFFFAOYSA-N 1-(3-methylbutyl)-3-(2-methylpropyl)-7h-purine-2,6-dione Chemical compound O=C1N(CCC(C)C)C(=O)N(CC(C)C)C2=C1NC=N2 HRWQHFZQHIUCCC-UHFFFAOYSA-N 0.000 claims 4
- SUTYGHGRSKMVOB-UHFFFAOYSA-N 3-ethyl-8-(1-phenylethyl)-7H-purine-2,6-dione Chemical compound CCn1c2nc([nH]c2c(=O)[nH]c1=O)C(C)c1ccccc1 SUTYGHGRSKMVOB-UHFFFAOYSA-N 0.000 claims 4
- ATPSJRIIRXKPER-UHFFFAOYSA-N 8-methoxy-1,3,7-trimethylpurine-2,6-dione Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=C(OC)N2C ATPSJRIIRXKPER-UHFFFAOYSA-N 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 229960004559 theobromine Drugs 0.000 claims 4
- 239000005995 Aluminium silicate Substances 0.000 claims 2
- 235000013312 flour Nutrition 0.000 claims 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 claims 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims 2
- 239000008188 pellet Substances 0.000 claims 1
- 230000000361 pesticidal effect Effects 0.000 abstract description 23
- 230000000694 effects Effects 0.000 description 38
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 21
- 229960001948 caffeine Drugs 0.000 description 21
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 21
- 229940095074 cyclic amp Drugs 0.000 description 21
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 20
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 20
- -1 raethylparaoxon Chemical compound 0.000 description 16
- 241000238631 Hexapoda Species 0.000 description 14
- 241000255908 Manduca sexta Species 0.000 description 14
- 240000007154 Coffea arabica Species 0.000 description 12
- 230000003389 potentiating effect Effects 0.000 description 12
- 241001122767 Theaceae Species 0.000 description 11
- 235000013616 tea Nutrition 0.000 description 11
- MZCHBOYMVBQHQC-UHFFFAOYSA-N n-(4-chloro-2-methylphenyl)-n'-methylmethanimidamide Chemical compound CN=CNC1=CC=C(Cl)C=C1C MZCHBOYMVBQHQC-UHFFFAOYSA-N 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000030621 adenylate cyclase Human genes 0.000 description 8
- 108060000200 adenylate cyclase Proteins 0.000 description 8
- 235000016213 coffee Nutrition 0.000 description 8
- 235000013353 coffee beverage Nutrition 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 239000002917 insecticide Substances 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 239000000575 pesticide Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241001674044 Blattodea Species 0.000 description 6
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 6
- 230000001887 anti-feedant effect Effects 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 231100000673 dose–response relationship Toxicity 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- QHGUCRYDKWKLMG-QMMMGPOBSA-N (R)-octopamine Chemical compound NC[C@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-QMMMGPOBSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 241000533293 Sesbania emerus Species 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000000749 insecticidal effect Effects 0.000 description 5
- 229940075420 xanthine Drugs 0.000 description 5
- PFWLFWPASULGAN-UHFFFAOYSA-N 7-methylxanthine Chemical class N1C(=O)NC(=O)C2=C1N=CN2C PFWLFWPASULGAN-UHFFFAOYSA-N 0.000 description 4
- RTAPDZBZLSXHQQ-UHFFFAOYSA-N 8-methyl-3,7-dihydropurine-2,6-dione Chemical class N1C(=O)NC(=O)C2=C1N=C(C)N2 RTAPDZBZLSXHQQ-UHFFFAOYSA-N 0.000 description 4
- 102000009346 Adenosine receptors Human genes 0.000 description 4
- 108050000203 Adenosine receptors Proteins 0.000 description 4
- STUSTWKEFDQFFZ-UHFFFAOYSA-N Chlordimeform Chemical compound CN(C)C=NC1=CC=C(Cl)C=C1C STUSTWKEFDQFFZ-UHFFFAOYSA-N 0.000 description 4
- 235000007460 Coffea arabica Nutrition 0.000 description 4
- 241000256010 Manduca Species 0.000 description 4
- QHGUCRYDKWKLMG-MRVPVSSYSA-N Octopamine Natural products NC[C@@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-MRVPVSSYSA-N 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 239000000556 agonist Substances 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000002858 neurotransmitter agent Substances 0.000 description 4
- 108010003516 norsynephrine receptor Proteins 0.000 description 4
- 229960001576 octopamine Drugs 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000000296 purinergic P1 receptor antagonist Substances 0.000 description 4
- 150000003212 purines Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- PJFMAVHETLRJHJ-UHFFFAOYSA-N 8-phenyltheophylline Chemical compound N1C=2C(=O)N(C)C(=O)N(C)C=2N=C1C1=CC=CC=C1 PJFMAVHETLRJHJ-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000255925 Diptera Species 0.000 description 3
- 241000258937 Hemiptera Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102000001253 Protein Kinase Human genes 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108060006633 protein kinase Proteins 0.000 description 3
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- GMSNIKWWOQHZGF-UHFFFAOYSA-N 3-methyl-9H-xanthine Chemical compound O=C1NC(=O)N(C)C2=C1N=CN2 GMSNIKWWOQHZGF-UHFFFAOYSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- 241000239290 Araneae Species 0.000 description 2
- 241000238421 Arthropoda Species 0.000 description 2
- 0 C*/C(/N(*)CCCCC1)=C1\N* Chemical compound C*/C(/N(*)CCCCC1)=C1\N* 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- 241000256113 Culicidae Species 0.000 description 2
- 241001124144 Dermaptera Species 0.000 description 2
- 241000257303 Hymenoptera Species 0.000 description 2
- 241000256602 Isoptera Species 0.000 description 2
- 241000254158 Lampyridae Species 0.000 description 2
- 241000255777 Lepidoptera Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241000258913 Oncopeltus fasciatus Species 0.000 description 2
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 description 2
- 102000014750 Phosphorylase Kinase Human genes 0.000 description 2
- 108010064071 Phosphorylase Kinase Proteins 0.000 description 2
- 241001674048 Phthiraptera Species 0.000 description 2
- 241000258242 Siphonaptera Species 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 241000693030 Vanessa cardui Species 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 2
- 229960001140 cyproheptadine Drugs 0.000 description 2
- DFBKLUNHFCTMDC-PICURKEMSA-N dieldrin Chemical compound C([C@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@H]2[C@@H]2[C@H]1O2 DFBKLUNHFCTMDC-PICURKEMSA-N 0.000 description 2
- 229950006824 dieldrin Drugs 0.000 description 2
- NGPMUTDCEIKKFM-UHFFFAOYSA-N dieldrin Natural products CC1=C(Cl)C2(Cl)C3C4CC(C5OC45)C3C1(Cl)C2(Cl)Cl NGPMUTDCEIKKFM-UHFFFAOYSA-N 0.000 description 2
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 2
- 229960004166 diltiazem Drugs 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papavarine Natural products C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 description 2
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical class C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 2
- 229960004919 procaine Drugs 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- POSZUTFLHGNLHX-KSBRXOFISA-N tris maleate Chemical compound OCC(N)(CO)CO.OCC(N)(CO)CO.OC(=O)\C=C/C(O)=O POSZUTFLHGNLHX-KSBRXOFISA-N 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- ZCVAOQKBXKSDMS-AQYZNVCMSA-N (+)-trans-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-AQYZNVCMSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- FMTFEIJHMMQUJI-NJAFHUGGSA-N 102130-98-3 Natural products CC=CCC1=C(C)[C@H](CC1=O)OC(=O)[C@@H]1[C@@H](C=C(C)C)C1(C)C FMTFEIJHMMQUJI-NJAFHUGGSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- MUTOERQVXAXVTM-UHFFFAOYSA-N 3-(2-methylpropyl)-7h-purine-2,6-dione Chemical class O=C1NC(=O)N(CC(C)C)C2=C1NC=N2 MUTOERQVXAXVTM-UHFFFAOYSA-N 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- RCDRLZYAKDYXMM-UHFFFAOYSA-N 7-acetyl-1,3-dimethylpurine-2,6-dione Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C(=O)C RCDRLZYAKDYXMM-UHFFFAOYSA-N 0.000 description 1
- RYIGNEOBDRVTHA-UHFFFAOYSA-N 8-chlorotheophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC(Cl)=N2 RYIGNEOBDRVTHA-UHFFFAOYSA-N 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 241000766754 Agra Species 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241001427556 Anoplura Species 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 108090000312 Calcium Channels Proteins 0.000 description 1
- 102000003922 Calcium Channels Human genes 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 241001121020 Cetonia aurata Species 0.000 description 1
- 241000258920 Chilopoda Species 0.000 description 1
- 241000238586 Cirripedia Species 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- 241001427559 Collembola Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000256054 Culex <genus> Species 0.000 description 1
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
- 241000709823 Dictyoptera <beetle genus> Species 0.000 description 1
- 241000258963 Diplopoda Species 0.000 description 1
- 241001414834 Ephemeroptera Species 0.000 description 1
- 241000242711 Fasciola hepatica Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- PLDUPXSUYLZYBN-UHFFFAOYSA-N Fluphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 PLDUPXSUYLZYBN-UHFFFAOYSA-N 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 241000545744 Hirudinea Species 0.000 description 1
- 101000834981 Homo sapiens Testis, prostate and placenta-expressed protein Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241001124553 Lepismatidae Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 241000257226 Muscidae Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 241000819999 Nymphes Species 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000238675 Periplaneta americana Species 0.000 description 1
- 108010065084 Phosphorylase a Proteins 0.000 description 1
- 108010065081 Phosphorylase b Proteins 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 241000242594 Platyhelminthes Species 0.000 description 1
- 241000501478 Plecoptera <stoneflies, order> Species 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241001415024 Psocoptera Species 0.000 description 1
- 239000000877 Sex Attractant Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- IDCBOTIENDVCBQ-UHFFFAOYSA-N TEPP Chemical compound CCOP(=O)(OCC)OP(=O)(OCC)OCC IDCBOTIENDVCBQ-UHFFFAOYSA-N 0.000 description 1
- 241000254105 Tenebrio Species 0.000 description 1
- 241000255588 Tephritidae Species 0.000 description 1
- 102100026164 Testis, prostate and placenta-expressed protein Human genes 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 241001414989 Thysanoptera Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000254113 Tribolium castaneum Species 0.000 description 1
- 241000254112 Tribolium confusum Species 0.000 description 1
- 241001439624 Trichina Species 0.000 description 1
- 108091093126 WHP Posttrascriptional Response Element Proteins 0.000 description 1
- 241001414985 Zygentoma Species 0.000 description 1
- YPDSOAPSWYHANB-UHFFFAOYSA-N [N].[F] Chemical compound [N].[F] YPDSOAPSWYHANB-UHFFFAOYSA-N 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229940121359 adenosine receptor antagonist Drugs 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 229940024113 allethrin Drugs 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 229940125516 allosteric modulator Drugs 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000003559 chemosterilizing effect Effects 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000002036 chloroform fraction Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 description 1
- 229960004170 clozapine Drugs 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 238000012272 crop production Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- RDBIYWSVMRVKSG-UHFFFAOYSA-N dimetilan Chemical compound CN(C)C(=O)OC=1C=C(C)N(C(=O)N(C)C)N=1 RDBIYWSVMRVKSG-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000004662 dithiols Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 208000006275 fascioliasis Diseases 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 230000003031 feeding effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229960002690 fluphenazine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 210000000609 ganglia Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000854 inhibitional effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 239000002949 juvenile hormone Substances 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000004031 partial agonist Substances 0.000 description 1
- 235000021400 peanut butter Nutrition 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960001999 phentolamine Drugs 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003018 phosphorus compounds Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 208000037974 severe injury Diseases 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000036435 stunted growth Effects 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008791 toxic response Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Definitions
- the present invention is directed to a method for controlling a pest comprising bringing into contact with the pest a pest-controlling amount of a compound from the group comprising derivatives of xanthine.
- DCDM which is the probable in vivo metabolite of CDM is about six-fold more potent than octopamine itself as a partial agonist of light organ octopamine-stimulated adenylate cyclase. Stimulation by the formamidines resulted in increased formation of the intracellular messenger, cyclic AMP (cAMP).
- cAMP cyclic AMP
- cyclic AMP as a "second messenger" has led to the accepted model that a hormone or neuro transmitter binds at a cell-membrane bound receptor, which activates adenylate cyclase to a form capable of converting ATP in the cytoplasm of the cell into cAMP. cAMP then relays the signal brought by the hormone or neuro transmitter from the membrane to the interior of the cell. Agonists of the hormone or neuro transmitter are, by definition, capable of eliciting the same response (see, for example, Nathanson and Greengard, Scientific American, 237: 108-119 (1977)).
- cAMP stimulates the conversion of inactive phosphorylase b into phosphorylase a, a reaction catalysed by phosphorylase kinase.
- This reaction is, in turn, catalysed by an enzyme, now called protein kinase, which occurs in an inactive and active form.
- protein kinase catalysed by an enzyme, now called protein kinase, which occurs in an inactive and active form.
- active form catalyses the phosphorylation of inactive phosphorylase kinase by ATP to yield the active phosphorylated form by a reaction in which ATP is the phosphate-group donor.
- Protein kinase the key enzyme in linking cAMP to the phosphorylase system and to other cyclic AMPregulated processes, is an allosteric enzyme, that is, an enzyme whose reactivity with another molecule is altered by combination with a third molecule that is not a substrate. Its inactive form contains two types of subunits, a catalytic (C) subunit and a regulatory (R) subunit which inhibits the catalytic subunit.
- C catalytic
- R regulatory
- cAMP is the allosteric modulator of protein kinase, binding to a specific site on the regulatory subunit and causing the inactive CR complex to dissociate, yielding R-cAMP complex, and the free C subunit, which is now catalytically active.
- cAMP removes the inhibition of enzyme activity that is imposed by the binding of the regulatory subunit (Lehninger, Biochemistry, Second Edition, pages 812-813).
- the enzyme responsible for the destruction of cAMP is phosphodiesterase, which catalyzes the hydrolytic reaction as follows:
- Calva United States Patent 2,362,614, describes fluorine-containing insecticides. Disclosed are the hydrofluoric acid addition compounds of ammonia-substituted compounds giving rise to primary, secondary or tertiary amines and polyamines. Insecticidal activity is described as derived from the direct combination of the fluorine-nitrogen link. Caffeine is included in the patent disclosure among the "alkylamines with or without substituent groups.”
- French Patent 2,138,186 to Aries discloses insecticidal compositions of urinylphosphate esters which are stabilized by purine derivatives. Included among the purine derivatives are purines substituted in the 2, 4 and 8 positions. No insecticidal activity, however, is attributed to the purine compounds, the compounds performing the function of stabilizing the active phosphorus compounds.
- xanthine derivatives including caffeine and theophylline
- caffeine and theophylline are found in berries, seeds, and leaves of a number of species, including tea, coffee, cocoa and cola.
- methylxanthines are one of the most frequently used stimulants employed by the human population, their natural function in plants was not known up to the present. It is known, however, that to discourage insect feeding, many plants have evolved endogenous chemical defenses, ranging from specific toxins and substances with pheromone-like activity to less specific bitter-tasting aversive substances.
- this invention comprises a method of pest control comprising bringing into contact with said pest a pest-controlling amount of an agent consisting essentially of a compound having the general formula (I) or (II):
- X is oxygen or sulfur;
- R 1 , R 2 , R 3 , R 4 and R 5 are selected from hydrogen; aliphatic and cycloaliphatic hydrocarbons having 1-8 carbon atoms; substituted aliphatic and cycloaliphatic hydrocarbons substituted with 1-3 halogen atoms, lower alkyl (C 1 -C 4 ), or hydroxy; alkoxy having 1-6 carbon atoms; aromatic; halo, hydroxy, or lower alkyl-substituted aromatic; phenoxy; substituted phenoxy; and the like, and acid addition salts of the above, where at least one of R 1 , R 2 , R 3 , or R 5 is other than hydrogen.
- said agent is further defined by having a V max of more than 50%, where V max is expressed as the inhibition of feeding at the highest dose used, usually a 3% spray solution, and an EC 50 of less than 3% (gm/100 ml), EC 50 being the spray concentration required to cause 50% inhibition of feeding, as calculated from dose-response curves.
- the most preferred compounds have a K i of not more than 0.1, where K i is defined as the concentration in millimoles/liter of the xanthine derivative required to produce a 50% in vitro inhibition of the phosphodiesterase activity in tobacco hornworm nerve cord, using the conditions described.
- Figure 1A shows the effect on tobacco hornworm body weight of powdered coffee beans or caffeine incorporated into artificial media.
- Figure 1B shows the dose-dependent antifeeding effect of caffeine.
- Figure 1C is a graph quantitating the antifeeding effect of caffeine and other xanthine derivatives applied as a spray to tomato leaves subsequently exposed to tobacco hornworm larvae for 4 days.
- Figure 1D is a graph showing the effect of the same xanthine derivatives on inhibiting cyclic AMP phosphodiesterase activity in homogenates of tobacco hornworm nerve cord.
- Figure 2 is a graph showing the phosphodiesterase inhibiting activity of various xanthine derivatives in tobacco hornworm nerve cord.
- pest-controlling or “pest-controlling activity,” used throughout the specification andclaims, are meant to include any pesticidal (killing) or pestistatic (inhibiting, maiming or generally interfering) activities of a composition against a given pest.
- these terms not only include killing, but also include such activities as those of chemisterilants which produce sterility in insects by preventing the production of ova or sperm, by causing death of sperm or ova, or by producing severe injury to the genetic material of sperm or ova, so that tha larvae that are produced do not develop into mature progeny.
- inhibiting the feeding is meant to include both pesticidal activity wherein the pest is killed by the compound, as well as the situation wherein the feeding activity of the larvae is substantially affected and limited.
- pest is meant any phosphodiesterase-containing invertebrate.
- These pests include, but are not limited to, round worms (for example, hookworms, trichina, and ascaris); flat worms (for example, liver flukes and tapeworms); jointed worms (for example, leeches); molluscs (for example, parasitic snails); and arthropods (insects, spiders, centipedes, millipedes, crustaceans (for example, barnacles)).
- arthropods included among the arthropods are ticks, mites (both plant and animal), lepidoptera (butterflies and moths and their larvae), hemiptera (bugs), homoptera (aphids, scales), and coleoptera (beetles).
- spiders anoplura (lice), diptera (flies and mosquitos), tricoptera, orthoptera (for example, roaches), odonta, thysanura (for example, silverfish), collembola (for example, fleas), dermaptera (earwigs), isoptera (termites), ephemerids (mayflies), plecoptera, malophaga (biting lice), thysanoptera, and siphonaptera (dictyoptera, psocoptera, and certain hymenoptera (for example, those whose larvae feed on leaves)).
- anoplura lice
- diptera flies and mosquitos
- tricoptera for example, roaches
- odonta for example, silverfish
- collembola for example, fleas
- dermaptera earwigs
- isoptera termites
- ephemerids mayflies
- plecoptera malophaga
- xanthine derivative or “methyl xanthine derivatives” are meant compounds having the general formula (I) or (II):
- X is oxygen or sulfur
- R 1 , R 2 , R 3 , R 4 and R 5 are selected from hydrogen; aliphatic and cycloaliphatic hydrocarbons having 1-8 carbon atoms; aliphatic and cycloaliphatic hydrocarbons substituted with 1-3 halogen atoms, lower alkyl (C 1 -C 4 ), or hydroxy; alkoxy having 1-6 carbon atoms; aromatic; halo, hydroxy, or lower alkyl-substituted aromatic; phenoxy; substituted phenoxy; and the like, and further wherein at least one of R 1 , R 2 , R 3 or R 5 is other than hydrogen.
- Suitable aliphatic hydrocarbon compounds include alkyl, alkenyl, alkynyl and the like.
- alkyl hydrocarbons include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, tert-pentyl, hexyl, heptyl, octyl, and the like.
- Suitable alkenyl hydrocarbons are those having 2-8 carbon atoms and may include vinyl, allyl, isopropenyl, 1-propenyl, 2-butenyl, 3-pentenyl, 2-, 3-, or 4-hexenyl, and the like.
- Suitable alkynyl hydrocarbons are those having 2-8 carbon atoms and may include ethynyl, 2-propynyl, 2-butynyl, 3-pentynyl, 3-hexynyl, 2-, 3-, or 4-heptynyl, and the like.
- Suitable cylcoaliphatic groups include those having 3-8 carbon atoms, for example, cyclopentyl, cycloheptanyl, cyclohexanyl, cyclopentenyl, cyclohexynyl, and the like, as well as lower alkyl, halo or hydroxy substituted alkoxy groups.
- Suitable alkoxy groups include methoxy, ethoxy, butoxy, pentoxy, and the like.
- Suitable aromatic groups include phenyl or naphthyl.
- substituted aromatic groups are phenyl substituted in the ortho, meta, and/or para positions with lower alkyl groups having 1-4 carbon atoms, halogens, and hydroxy.
- the fluoride salts are generally excluded; where the compounds are intended as pestistats, caffeine is excluded.
- R 2 increases activity substantially, with 3-isobutyl xanthine derivatives demonstrating superior effectiveness among the preferred compounds.
- substitution of small to medium (methyl, ethyl, propyl, i-propyl) groups in the 1-position ( R 1 ) increases activity.
- Small to medium group substitution on the 7-position ( R 3 ) also will enhance activity, as will certain small to medium group in the 8-pos ⁇ tion (R 4 ).
- chloro or bulky substituent in the 8-position decreases activity as do certain substitutions in the 9-position ( R 5 ).
- the preferred compounds of the present invention are further defined as those compounds having a V max of more than 50% inhibition of feeding and an EC 50 of less than a 3% (gm/100 ml) concentration of spray.
- V max is expressed as the percent inhibition of feeding at the highest dose used (usually a 3% spray solution).
- EC 50 is the spray concentration (as calculated from dose-response curves) required to cause 50% inhibition of feeding. Inhibition of feeding is determined at a time when untreated leaves show 20% of leaf area remaining. Calculation is then made by determining the percent leaf area remaining on leaves sprayed with drugs minus 20 divided by 80 (the maximal inhibition of feeding possible). The inhibition of feeding determination will be described in detail below. Basically, leaves are eaten by first-instar Manduca sexta which are placed at 6 per leaf.
- methylxanthines are known to inhibit phosphodiesterase (PDE), enzymes which hydrolyze cAMP.
- Rail, T. W. Pharmacological Bases of Therapeutics, A. G. Gillman, L. Goodman, A. Gillman, Editors (MacMillan, New York, 1980), p. 592; Sutherland, E. W., et al., Journal of Biological Chemistry, 232: 1077 (1958); and Butcher, R. W., et al., Journal of Biological Chemistry, 237: 1244 (1962).
- the similarity of the graphs in Figures 1C and ID demonstrates a strong correlation between PDE inhibition and pesticidal and pestistatic activity. This correlation is further evaluated in Examples 15 through 42 below.
- the most preferred compounds according to the present invention are those xanthine derivatives according to structural formulas (I) and (II) which also demonstrate a K i of 0.1 mM or less, wherein K- is defined as the concentration of xanthine derivative necessary to produce a 50% inhibition of enzyme activity for hornworm nerve cord PDE. Inhibition of phosphodiesterase activity for hornworm nerve cord for the purposes of determining K i within the meaning of this invention is determined in accordance with the methodology set out in Examples 8-11.
- the pest-controlling agents of the present invention may be formulated as dusts, water dispersions, emulsions and solutions. They may comprise accessory agents such as dust carriers, solvents, emulsifiers, wetting and dispersing agents, stickers, deodorants, and masking agents (see, for example. Encyclopedia of Chemical Technology, Volume 13, pages 416 et seq.).
- Dusts generally will contain low concentrations, 0.1-20%, of the compounds, although ground preparations may be used and diluted.
- Carriers commonly include organic flowers, sulfur, silicon oxides, lime, gypsum, talc, pyrophyllite, bentonite, kaolins, attapulgite, and volcanic ash. Selection of the carrier may be made on the basis of compatibility with the desired pest control composition (including pH, moisture content, and stability), particle size, abrasiveness, absorbability, density, wettability and cost.
- the agent of the invention, alone or in combination, and eluent is made by a variety of simple operations such as milling, solvent impregnations, fusing and grinding. Particle sizes usually range from 0.5-4.0 microns in diameter.
- Wettable powders may be prepared by blending the agents of the invention in high concentrations, usually from 15-95%, with a dust carrier such as bentonite which wets and suspends properly in water. Twenty-two percent of a surface-active agent is usually added to improve the wetting and suspendability of the powder.
- the pest-controlling agents may also be used in granules, which are pelleted mixtures of the agents, usually at 2.5-10%, and a dust carrier, for example, adsorptive clay, bentonite or diatomaceous earth, and commonly within particle sizes of 250-590 microns.
- Granules may be prepared by impregnations of the carrier with a solution or slurry of the agents and may be used principally for mosquito larvae treatment or soil applications.
- the agent may also be applied in the form of an emulsion, which comprises a solution of the agents in water-immiscible organic solvents, commonly at 15-50%, with a few percent of surface active agent to promote emulsification, wetting, and spreading.
- emulsion comprises a solution of the agents in water-immiscible organic solvents, commonly at 15-50%, with a few percent of surface active agent to promote emulsification, wetting, and spreading.
- the choice of solvent is predicated upon solubility, safety to plants and animals, volatility, flammability, compatibility, odor and cost.
- the most commonly used solvents are kerosene, xylenes, and related petroleum fractions, methylisobutyIketone, and amyl acetate. Water emulsion sprays from such emulsive concentrates may be used for plant protection and for household insect control.
- the agents may also be mixed with baits, usually comprising 1-5% of agents with a carrier especially attractive to insects.
- Carriers include sugar for houseflies, protein hydrolysate for fruit flies, bran for grasshoppers, and honey, chocolate, or peanut butter for ants.
- the agents may be included in slow release formulations which incorporate non-persistent compounds, insect growth regulators and sex pheromones in a variety of granular microencapsulated and hollow fiber preparations.
- the pest-controlling agents of the present invention may be applied depending on the properties of the particular pest-controlling compound, the habits of the pest to be controlled, and the site of the application to be made. It may be applied by spraying, dusting or fumigation.
- Doses of the weight of the ingredients may typically vary between 0.001 and 100 pounds/acre, preferably between 0.001-5 pounds/acre.
- Sprays are the most common means of application and generally will involve the use of water as the principal carrier, although volatile oils may also be used.
- the pest-controlling agents of the invention may be used in dilute sprays (for example, 0.001-10%) or in concentrate sprays in which the composition is contained at 10-98%, and the amount of carrier to be applied is quite reduced.
- the use of concentrate and ultra-low volume sprays will allow the use of atomizing nozzles producing droplets of 30-80 microns in diameter. Spraying may be carried out by airplane or helicopter.
- Aerosols may also be used to apply the pest-controlling agents. These are particularly preferred as space sprays for application to enclosures, particularly against flying insects. Aerosols are applied by atomizing amounts of liquified gas dispersion or bomb, but can be generated on a larger scale by rotary atomizers or twin-fluid atomizers.
- a simple means of pest-controlling agent dispersal is by dusting.
- the pest-controlling agent is applied by introducing a finely divided carrier with particles typically of 0.5-3 microns in diameter into a moving air stream.
- xanthine derivatives were tested on natural feeding substrates, such as tomato leaves, the xanthine derivatives bein ⁇ those compounds wherein at least one of R 1 , R 2 , R 3 , and R 5 are other than hydrogen.
- Figure 1B shows a typical result for caffeine.
- Fi ⁇ ure 1C (which guantitates the amount of leaf remaining) summarizes the dose-response curves for caffeine (Example 4), theophylline (Example 5), and the svnthetic compound.
- IBMX 1-methyl-3-i sobutylxa nth i ne (IBMX) (Example 6).
- IBMX 1-methyl-3-i sobutylxa nth i ne
- Nerve cord was dissected from 40-60 mm long M. sexta larvae, cleaned, and homogenized (2 mg/ml) in 6 Mm Tris-maleate, pH 7.4. PDE activity was measured (4 min. incubation at 30°C) in an assay system (0.1 ml) containing 80 mM Tris-maleate, pH 7.4; 6 mM Mg-SO 4 ; 10 -7 M 3 H-cyclic AMP; and tissue homogenate (0.02 ml).
- Nerve cord was evaluated in the presence and the absence of the xanthine derivative.
- the rate of formation of 3 H-5' AMP was measured using the technique described in Filburn,
- Larvae feeding on leaves treated with a 1% spray were found to contain an internal theophylline concentration of 4.1 ⁇ 1.1 mM (mean ⁇ deviation for two groups of six pooled animals). This concentration was sufficient to cause more than an 80% inhibition of hornworm nerve cord PDE activity in vitro. This observation tends to rule out the hypothesis wherein adenosine receptors are involved as a mechanism for the antifeeding effects of the xanthine derivatives, since, in vertebrates, xanthine derivatives such as theophylline are competitive adenosine receptor antagonists, but exert such antagonism at much lower concentrations, typically 1-25 micromoles. See Bruns, R., et al., Proceedings of the National Academy of Sciences, USA, 77: 5547 (1980); Williams, M., et al., Proceedings of the National Academy of Sciences, USA, 77: 6892 (1980).
- Xanthine derivatives have been reported to have calcium mobilizing effects (Links, J. R., et al., Circulation Research, 30: 367 (1972)). Xanthine derivatives are known to mobilize calcium from sarcoplasmic reticulum, an effect which is blocked by diltiazem or procaine. IBMX was evaluated with regard to antifeeding effects in the presence of both diltiazem and procaine, neither reversing the observed antifeeding effects.
- Xanthine derivatives have also been reported to affect calcium movement across the plasma membrane (Links, J. R., et al., supra; Saeki, K., et al., Life Sciences, 32: 2973 (1983)).
- the pestistatic and pesticidal effects of IBMX were evaluated in the presence of D600, verapamil, and nimodipine, compounds which are known to block plasma membrane calcium channels.
- the pestistatic and pesticidal effects of IBMX appeared unaffected by these compounds.
- caffeine has been reported to be 10-fold weaker than theophylline as an adenosine antagonist (Bruns, R., et al., supra), as demonstrated by the above Examples, caffeine was somewhat more potent than theophylline in preventing leaf eating and about equally potent as a PDE inhibitor. See Figures 1C and 1D. Also, whereas IBMX and theophylline are roughly equally potent in blocking adenosine receptors (Bruns, R., et al., supra) IBMX was about 10-fold more potent both in disruption of feeding and in PDE inhibition. See Figure 1D.
- the very potent adenosine antagonist, 8-phenyltheophylline (K ⁇ for adenosine receptor (0.12-1.0 micromoles) (Daly, J. W., Journal of Medicinal Chemistry, 25: 197 (1982); Bruns, R., et al., supra ) exerted little antifeeding effect and was a very weak PDE inhibitor (see Figures 1C and 1D).
- papavarine is an inhibitor of adenosine uptake, and it potentiates, rather than blocks physiological effects on adenosine receptors (Huang, M., et al., Life Sciences, 14: 489 (1974)). Taken together, these data are more consistent with a mechanism of action related to PDE inhibition than to adenosine blockade.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Utilisation des dérivés de la xanthine ayant la formule générale (I) ou (II) en tant que pesticides ou agents pestistatiques; sont également décrites des compositions pesticides et pestistatiques les contenant.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64808684A | 1984-09-07 | 1984-09-07 | |
US648,086 | 1984-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1986001724A1 true WO1986001724A1 (fr) | 1986-03-27 |
Family
ID=24599379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1985/001708 WO1986001724A1 (fr) | 1984-09-07 | 1985-09-06 | Pesticides derives de la xanthine |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP0193599A1 (fr) |
WO (1) | WO1986001724A1 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336769A (en) * | 1992-02-17 | 1994-08-09 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
US5447933A (en) * | 1991-11-08 | 1995-09-05 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
WO1996036638A1 (fr) * | 1995-05-19 | 1996-11-21 | Chiroscience Limited | Xanthines et leur utilisation therapeutique |
US6090816A (en) * | 1994-12-13 | 2000-07-18 | Euro-Celtique S.A. | Aryl thioxanthines |
US6239166B1 (en) * | 1997-04-24 | 2001-05-29 | Robert H. Black | Compositions for killing dust mites and methods of using same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1653710A (en) * | 1925-10-27 | 1927-12-27 | Kitchin John Colby | Antirodent preparation |
US2362614A (en) * | 1940-03-11 | 1944-11-14 | Jose B Calva | Insecticides |
US3663692A (en) * | 1969-12-29 | 1972-05-16 | Morley R Kare | Methods of bird control |
-
1985
- 1985-09-06 EP EP19850904714 patent/EP0193599A1/fr not_active Withdrawn
- 1985-09-06 WO PCT/US1985/001708 patent/WO1986001724A1/fr unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1653710A (en) * | 1925-10-27 | 1927-12-27 | Kitchin John Colby | Antirodent preparation |
US2362614A (en) * | 1940-03-11 | 1944-11-14 | Jose B Calva | Insecticides |
US3663692A (en) * | 1969-12-29 | 1972-05-16 | Morley R Kare | Methods of bird control |
Non-Patent Citations (14)
Title |
---|
CADENA-GOMEZ, Abstracts of the American Phytopathological Society, Caribbean Division, 73, pg. 121 (1983) * |
CLARK, Ent. Exp. and Appl., Vol. 29, pp. 189-197 (1981) * |
JANZEN et al., Phytochemistry, 16, pp. 223-227 (1977) * |
KING, Chemicals Evaluated as Insecticides and Repellents, pp. 1-21, 100-101 (1954) * |
McDANIEL, Insect Physiol. Vol. 20, pp. 245-252 (1974) * |
MOFFETT et al., Comp. Biochem. Physiol., Vol. 750, pp. 305-310 (1983) * |
RIZVI et al. Agricultural and Biological Chemistry, 45, pp. 1255-6 (1981) * |
RIZVI et al., Indian Journal of Experimental Biology, 18, pp. 777-8 (1980) * |
RIZVI et al., Journal of Applied Entomology, 90, pp. 378-81 (1980) * |
ROJAKOVICK et al, Pesticide Biochemistry and Physiology, 6, pp. 10-19 (1976) * |
SRINIVASAN et al., J. of Toxicology and Enivronmental Health, Vol. 2. pp. 569-576 (1977) * |
SRINIVASAN et al., Toxicology Letters, 3, pp. 101-105 (1979) * |
SRINIVASAN et al., Toxicology Letters, Vol. 3, pp. 229-232 (1979) * |
TARGA et al., Brazil J. Genetics, 4, pp. 669-677 (1982) * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5447933A (en) * | 1991-11-08 | 1995-09-05 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
US5336769A (en) * | 1992-02-17 | 1994-08-09 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
US6090816A (en) * | 1994-12-13 | 2000-07-18 | Euro-Celtique S.A. | Aryl thioxanthines |
WO1996036638A1 (fr) * | 1995-05-19 | 1996-11-21 | Chiroscience Limited | Xanthines et leur utilisation therapeutique |
AU692104B2 (en) * | 1995-05-19 | 1998-05-28 | Darwin Discovery Limited | Xanthines and their therapeutic use |
US5821366A (en) * | 1995-05-19 | 1998-10-13 | Chiroscience Limited | Xanthines and their therapeutic use |
US6124288A (en) * | 1995-05-19 | 2000-09-26 | Darwin Discovery, Ltd. | Xanthines and their therapeutic use |
US6239166B1 (en) * | 1997-04-24 | 2001-05-29 | Robert H. Black | Compositions for killing dust mites and methods of using same |
Also Published As
Publication number | Publication date |
---|---|
EP0193599A1 (fr) | 1986-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4883801A (en) | Xanthine derivative pest control agents | |
Nathanson | Caffeine and related methylxanthines: possible naturally occurring pesticides | |
US4678775A (en) | Method of controlling pests | |
Perry et al. | Insecticides in agriculture and environment: retrospects and prospects | |
RU2113120C1 (ru) | Акарицидное средство, применение и способ борьбы с клещами | |
KR100522446B1 (ko) | 아실 코에이:콜레스테롤 아실 트란스퍼라제의 저해활성을갖는 화합물 또는 그 염을 유효성분으로 하는 살충제 | |
KR100943983B1 (ko) | 피리피로펜 유도체 및 이를 포함하는 살충제 조성물 | |
US4902690A (en) | Pest controlling compositions | |
US5366975A (en) | Invertebrate phenylethanolamine transporter and the use thereof | |
PL155723B1 (en) | Pesticide in particular against insects, nematodes and mites | |
RU2077201C1 (ru) | Производные 1-фенилимидазола, способ борьбы с вредителями сельского хозяйства и композиция для пестицидной обработки | |
WO1986001724A1 (fr) | Pesticides derives de la xanthine | |
JP4864269B2 (ja) | 農薬としての3−チオメチルピラゾール | |
JP4630062B2 (ja) | 害虫制御のためのエレモフィロンおよびエレモフィロン誘導体 | |
Silva et al. | Structure–activity relationships of pyrrolizidine alkaloids in insect chemical defense against the orb-weaving spider Nephila clavipes | |
WO1985005008A1 (fr) | Compositions utilisees dans la lutte contre les parasites | |
Hirashima et al. | Effect of five-membered cyclic phosphorothionates on larval growth, trehalase, digestive enzymes, acetylcholinesterase, and cyclic adenosine 3′, 5′-monophosphate level of Tribolium castaneum and Musca domestica | |
KR100836172B1 (ko) | 아졸계 화합물을 유효성분으로 하는 살충제 조성물 | |
KR101067196B1 (ko) | 포르핀계 화합물인 페어포비드 에이 메틸에스터 또는 감잎 추출물을 유효성분으로 함유하는 아실-코에이:콜레스테롤 아실트란스퍼라제의 활성 저해제 및 살충제용도 | |
US3105000A (en) | Organo-tin and organo-sulphur parasiticides | |
JPS63126804A (ja) | 農園芸用殺虫組成物 | |
KR101614095B1 (ko) | 담쟁이의 용매 추출물의 살충제 조성물 | |
US3005841A (en) | Bromine-containing organo phosphate | |
Wigglesworth et al. | The mode of action of DDT | |
JPS6372608A (ja) | 農園芸用殺虫殺菌組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |